# Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection

> **NCT03955172** · NA · RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 20 (estimated)

## Conditions studied

- Kidney Transplant Failure and Rejection

## Interventions

- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT03955172
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-12-03
- **Primary completion:** 2027-12-03
- **Final completion:** 2027-12-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03955172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03955172, "Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03955172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*